Eikon Therapeutics, Inc. Loss At -$86.112 Mln In Q3
(RTTNews) - Eikon Therapeutics, Inc. (EIKN) revealed Loss for third quarter of -$86.112 million
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.